Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV003159413 | SCV003853012 | pathogenic | not provided | 2023-11-07 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV003615931 | SCV004394354 | pathogenic | Intellectual disability, autosomal dominant 5 | 2024-06-15 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gly391Alafs*12) in the SYNGAP1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SYNGAP1 are known to be pathogenic (PMID: 23161826, 23708187, 26989088). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SYNGAP1-related conditions. ClinVar contains an entry for this variant (Variation ID: 2446583). For these reasons, this variant has been classified as Pathogenic. |
Clinical Genetics Laboratory, |
RCV003159413 | SCV005196858 | pathogenic | not provided | 2022-05-27 | criteria provided, single submitter | clinical testing |